Paragon 28 Investor Fails to Advance Inventory Accounting Suit

Paragon 28 Inc., now a subsidiary of Zimmer Biomet Holdings Inc., and former executives finished off investor allegations that the medical device company concealed accounting and inventory problems that inflated financial results.

The investor leading the case sufficiently alleged inventory management problems, but not executives’ knowledge of them or their potential impact on financials for securities fraud claims, Judge Philip A. Brimmer said, dismissing the case with finality Tuesday.

Under investor Nicholas Tiedt’s theory, Paragon issued a restatement in 2024 falsely attributing incorrect financial metrics to an accounting error over the calculation of excess inventory when the real cause ...